Target intelligence / Profile preview

Ephrin type-A receptor (EPHA (for the family); individual members are abbreviated as EPHA1, EPHA2, etc.)

Target
EPHA (for the family); individual members are abbreviated as EPHA1, EPHA2, etc.
Molecular classification
Receptor tyrosine kinase, Receptor
01

Overview

Ephrin type-A receptors are a subclass within the largest known family of receptor tyrosine kinases. These membrane-bound proteins mediate contact-dependent bidirectional signaling through interactions with ephrin-A ligands on adjacent cells. EphA receptors play critical roles in embryonic development—particularly axon guidance, tissue boundary formation, and cell migration—as well as adult processes such as angiogenesis and stem cell differentiation. In humans, there are nine known EphA receptors (EPHA1–8 and EPHA10). Dysregulation or altered expression of these receptors has been implicated in cancer progression and other diseases involving abnormal cell communication or movement. Drugs targeting this family typically act by inhibiting their intrinsic tyrosine kinase activity. Note: The "Ephrin type-A receptor" refers to a family comprising several closely related proteins; for structured data purposes it may be necessary to specify individual members such as "Ephrin type-A receptor 1" (EPHA1), "Ephrin type-A receptor 2" (EPHA2), etc., depending on context.

Other names
EPH receptor AErythropoietin-producing hepatoma receptorTyrosine-protein kinase receptor EPHEPH tyrosine kinase
02

Mechanism of action

Inhibition of tyrosine kinase activity (for inhibitors like fostamatinib)

03

Biological functions

Signal transductionCell migrationAxon guidanceFormation of tissue boundariesAngiogenesisCell proliferationApoptosis
04

Disease associations

Cancer (carcinogenesis)Neurodevelopmental disorders (via axon guidance and nervous system development)
05

Safety considerations

Potential effects on cell migration, angiogenesis, and developmental processes due to broad roles in cell signalingPossible off-target effects when inhibiting kinases involved in multiple physiological pathways
06

Interacting drugs

Fostamatinib

Beyond the preview

Go deeper on Ephrin type-A receptor (EPHA (for the family); individual members are abbreviated as EPHA1, EPHA2, etc.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ephrin type-A receptor (EPHA (for the family); individual members are abbreviated as EPHA1, EPHA2, etc.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call